These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3245180)

  • 21. [The use of L-DOPA for treating myocardial infarct patients].
    Bul'on VV; Khnychenko LK; Zavodskaia IS; Levina LI; Reznikova IS; Fedorov AIu
    Eksp Klin Farmakol; 1993; 56(2):28-30. PubMed ID: 8348032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of obsidan on the dynamics of the myocardial infarct zone in the 1st days of the disease].
    Ivanova LK
    Vrach Delo; 1980 Oct; (10):15-8. PubMed ID: 6108019
    [No Abstract]   [Full Text] [Related]  

  • 23. [Bolus molsidomine administration for induction of parenteral molsidomine therapy in acute myocardial infarct. Effect on systemic blood pressure].
    Klüsener W
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():7-9. PubMed ID: 7968912
    [No Abstract]   [Full Text] [Related]  

  • 24. [Continuous molsidomine infusion in acute myocardial infarct. Comparison with nitroglycerin infusion].
    Djonlagic H; Funke K; Lessmann J; Nitsche K; Kreymann G; Lipke M; Fuchs M
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():10-6. PubMed ID: 7968893
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of intravenous administration of nitroglycerin on the indicators of central hemodynamics in patients with acute myocardial infarction].
    Afonskaia NI; Ostrogorskiĭ IuM; Karpov IuA; Ivanishvili LO; Iasinovskiĭ VD
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):49-54. PubMed ID: 6416267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of terbutaline in patients with myocardial infarct and concomitant chronic obstructive diseases of the lungs].
    Aksel'rud MM; Ustinov AG; Tatarskiĭ AR; Godiaev MIa; Zasimov AA
    Sov Med; 1988; (3):61-4. PubMed ID: 3413553
    [No Abstract]   [Full Text] [Related]  

  • 27. [The hemodynamic effectiveness of molsidomine infusions in patients with acute coronary insufficiency].
    Krüger R; Grewe R
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():26-9. PubMed ID: 7968897
    [No Abstract]   [Full Text] [Related]  

  • 28. [The characteristics of the effect of obzidan on the cardiac hemodynamics in patients with an artificial pacemaker when used one time and over a course of treatment].
    Iskenderov BG; Tatarchenko IP
    Ter Arkh; 1996; 68(5):60-3. PubMed ID: 9082604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical pharmacokinetics and hemodynamics of ethacizin in the acute period of myocardial infarct].
    Beloborodov VL; Klimov AV; Tiukavkina NA; Kaverina NV; Pokazeeva ET
    Farmakol Toksikol; 1986; 49(5):32-6. PubMed ID: 3770172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of infarct size by early use of oral propranolol and verapamil in acute myocardial infarction.
    Gupta RC; Sharma SK; Arora YK; Tripathi K
    J Assoc Physicians India; 1985 Sep; 33(9):577-80. PubMed ID: 4093403
    [No Abstract]   [Full Text] [Related]  

  • 31. [Polycardiographic and radiocardiographic evaluation of the effect of glucagon on hemodynamics in recent myocardial infarct].
    Szmydt W; Kozłowska F; Krug H; Paradowski S
    Kardiol Pol; 1979; 22(4):427-34. PubMed ID: 385959
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of intravenous nitroglycerin on the hemodynamics and the degree of ischemia in experimental myocardial infarct].
    Stepina NI; Revenko VM
    Farmakol Toksikol; 1982; 45(4):46-8. PubMed ID: 6813140
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of obzidan in the acute period of myocardial infarct].
    Gvatua NA; Kravtsov VL; Ivanova LK; Shkliar LV; Shumakov VA
    Kardiologiia; 1980 Oct; 20(10):19-24. PubMed ID: 7441957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation using Tc-99m angioscintigraphy of the hemodynamic changes induced by orally administered propafenone in recent acute myocardial infarct].
    Zacà F; Rollo P; Bombardini T; Ghinelli M; Mattace R; Manetti CF; Malavolta E; Vaccarino R; Puddu P
    Cardiologia; 1988 Mar; 33(3):297-303. PubMed ID: 3401893
    [No Abstract]   [Full Text] [Related]  

  • 35. [The cardiotoxic properties of kordaron in acute myocardial ischemia and infarct].
    Spasov AA; Gurova NA; Panchenko TI
    Eksp Klin Farmakol; 1998; 61(6):25-30. PubMed ID: 9929812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propranolol decreases sympathetic nervous activity reflected by plasma catecholamines during evolution of myocardial infarction in man.
    Mueller HS; Ayres SM
    J Clin Invest; 1980 Feb; 65(2):338-46. PubMed ID: 7356683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacokinetic characteristics of propranolol in patients with a history of acute myocardial infarct].
    Katrukha SP; Kalenikov EI; Zagrebin SV; Kukes VG
    Farmakol Toksikol; 1987; 50(3):87-9. PubMed ID: 3609287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The treatment of acute myocardial infarctions with beta-receptor-blockers. II. Hemodynamic effects of propranolol with and without combination therapy with nitroglycerin (author's transl)].
    Lehmann HU; Oeff M; Witt E; Hochrein H
    Z Kardiol; 1981 Oct; 70(10):748-53. PubMed ID: 6795841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Actual problems of the treatment of acute myocardial infarction].
    Popov VG; Sidorenko BA; Gruzdev AK
    Kardiologiia; 1989 Oct; 29(10):31-6. PubMed ID: 2615155
    [No Abstract]   [Full Text] [Related]  

  • 40. [The efficacy of Capoten in different clinical courses of acute myocardial infarct].
    Mikashinovich ZI; Terent'ev VP; Shlyk SV; Suroedova RA; Shepelev AA
    Anesteziol Reanimatol; 1996; (5):39-44. PubMed ID: 9027252
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.